Obinna Okwelume

University of Alberta’s Timothy Caulfield receives James Kreppner Award


Tuesday, May 14, 2019

The 2018 Canadian Blood Services’ James Kreppner Award has been awarded to Timothy Caulfield, professor and research director in the Health Law Institute at the University of Alberta.   

Valued at $50,000, the award will support Professor Caulfield’s project to analyze the marketing practices of private cord blood banks, assess their claims, and consider how regulatory tools can help ensure services marketed are done in a scientifically informed and evidence-based manner.    

Image
Canadian Blood Services' James Kreppner Award awarded to Timothy Caulfield

“The entire Health Law Institute team is thrilled about this award, and we truly appreciate the opportunity to dig into the complex issues associated with donation, blood products and policy development,” says Professor Caulfield. “The research seems both timely and needed. We are lucky to have an award of this nature and hope our work will reflect James Kreppner's fearless analysis of controversial issues.”  

James Kreppner was a former board member of Canadian Blood Services, a lawyer, and a strong advocate for patients’ rights and blood safety. He suffered a severe form of hemophilia-A – a genetic disorder that makes it difficult for blood to clot, and his condition often required transfusions of blood products. In 1985, he became infected with HIV and hepatitis C through tainted blood products.  

Mr. Kreppner became a key figure in establishing the public inquiry into contaminated blood and testified twice before The Krever Commission. He was also a long-time volunteer and member of the Canadian Hemophilia Society before his passing ten years ago on May 14, 2009.   

This annual award named in his honour supports one high-quality research project that explores legal and policy questions relevant to the products and services provided by Canadian Blood Services. The award’s research priorities include the legal and regulatory aspects of (a) donation, collection, storage, and use of blood, blood products, and hematopoietic stem cells; and (b) organ and tissue donation and transplantation.   

Through a series of funding programs and research collaborations, the Canadian Blood Services’ Centre for Innovation conducts and supports research in key priority areas, including projects that span the translational continuum from “bench to bedside.”  

The 2019 competition for the James Kreppner Award will open for applications in Fall 2019 and will support one project with up to $50,000 for a period of one year.   

Find out more about current and past James Kreppner Award program projects:  

Further reading:  


Canadian Blood Services – Driving world-class innovation

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration.

The opinions reflected in this post are those of the author and do not necessarily reflect the opinions of Canadian Blood Services nor do they reflect the views of Health Canada or any other funding agency.

Nominations now open for the 2019 Canadian Blood Services Lifetime Achievement Award


Monday, May 13, 2019

Do you know someone who has made an outstanding contribution to the blood system in Canada?   

Who can be nominated?  

Recipients of the Canadian Blood Services Lifetime Achievement Award are individuals whose landmark contributions are recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad. 

To be nominated for the Canadian Blood Services Lifetime Achievement Award, an individual must have contributed significantly to improving the safety and/or quality of blood, blood products, stem cells and/or cord blood or has made noteworthy improvements or advances in transfusion or transplantation medicine practice. Their record of publication should be of significance and their professional reputation should be aligned with the goals and reputation of Canadian Blood Services, reflecting a quality culture driven by excellence. 

The award will be presented on September 23, 2019 in Ottawa at the annual national Honouring Canada’s Lifeline event where we honour our donors, volunteers, peer recruiters and partners from across the country and across our products for their outstanding dedication and achievements. 

 

What's the nomination process? 

Nomination requirements 

  • Provide a short introduction and summary in 150 words or less of the nominee’s contribution to improving the safety and/or quality of blood, blood products or stem cells, or contribution to advances in transfusion medicine practice. 
  • Present a brief biography including academic, research, clinical and administrative positions, awards or recognitions. 
  • Outline how the work of the nominee is set apart from the work of others in the field. 
  • Provide a nominee’s full current curriculum vitae and contact information for the nominee including full name, mailing address, telephone number(s) and email address. 
  • Provide name and contact information for the nominator(s). 

Note: Candidates should be unaware that they have been nominated for this award. 

Submit nominations in writing to the address below:  

By mail:  

Canadian Blood Services Lifetime Achievement Award Nominating Committee 

c/o Dr. Isra Levy, Vice President, Medical Affairs and Innovation 

Canadian Blood Services 

1800 Alta Vista Drive 

Ottawa, Ontario K1G 4J5 

By email:  

isra.levy@blood.ca    

 

Submission deadline: May 30, 2019 

The nominator of the awardee, and the nominee selected, will be notified by the end of June 2019. 

 

Past honourees 

The Canadian Blood Services Lifetime Achievement Award came into existence in 2002. To date, the Canadian Blood Services Board of Directors has selected the following individuals for this prestigious award: 

• Dr. John Bowman, 2002 

• Ms. Marie Cutbush Crookston, 2002 

• Dr. Morris A. Blajchman, 2003 

• Dr. Peter Pinkerton, 2004 

• Dr. John Freedman, 2006 

• Dr. Hans Messner, 2007 

• Mr. Justice Horace Krever, 2008 

• Dr. Gail Rock, 2009 

• Dr. Victor Blanchette, 2010 

• Dr. Allen Eaves and Dr. Connie Eaves, 2011 

• Dr. Celso Bianco, 2012 

• The Canadian Hemophilia Society, 2013 

• Dr. John Dossetor, 2013 

• Dr. Gershon Growe, 2014 

• Dr. Bruce McManus, 2015 

• Dr. David Lillicrap, 2016 

• Nancy Heddle, 2017 

• André Picard, 2018 

  

Image
2019 Canadian Blood Services Lifetime Achievement Award

Canadian Blood Services – Driving world-class innovation 

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation—bringing clarity and insight to an increasingly complex healthcare future. Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technologies, and build capacity through training and collaboration. Find out more about our research impact.

Book your donation